Skip to main content
Signal8

Whiting Samuel

SEC insider (Form 3/4/5 filer). CIK 0001870373. Chief Medical Officer at Tempest Therapeutics, Inc. (TPST). 1 reported Form 4/5 transaction since Sep 2024; latest on Jan 2, 2025. Located in BRISBANE, CA.

Companies Whiting Samuel has filed insider reports for

  • Tempest Therapeutics, Inc. (TPST): Officer, Chief Medical Officer
Whiting Samuel profile photo

Whiting Samuel

CIK: 0001870373

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Tempest Therapeutics, Inc. logo
TPST

Tempest Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Tempest Therapeutics, Inc. logo
    TPST

    Tempest Therapeutics, Inc.

    Jan 2, 2025
    Award

    Employee Stock Option (right to buy)

    Direct
    270K shares-

1-1 of 1